Key result
In patients with cutaneous melanoma, brown adipose tissue positivity was not associated with relapse-free survival or overall survival at any evaluated threshold.
Why the study?
BAT volume predicts tumour recurrence and mortality in cancer patients, but data on its role in melanoma progression and clinical outcomes remain limited.
Does brown adipose tissue activity predict relapse-free or overall survival in patients with cutaneous melanoma?
Observational (n=135)
No
Does brown adipose tissue activity predict relapse-free or overall survival in patients with cutaneous melanoma?
Retrospective analysis found no association between brown adipose tissue positivity on FDG-PET-CT and relapse-free or overall survival in patients with cutaneous melanoma.
Answers are grounded in this paper and cite their sources.
BAT status was not associated with melanoma outcomes here; larger studies are needed to clarify any prognostic role.
Background: Brown adipose tissue (BAT) activity has been suggested to play a role in cancer progression. Previous studies have shown that BAT activity is higher in patients with cancer, and that BAT volume is a predictor of tumour recurrence and mortality in patients with cancer, but the data on melanoma are limited. Patients and methods: Here, we re-analysed 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography (FDG-PET-CT) images from 135 patients with cutaneous melanoma treated at Turku University Hospital between 2012 and 2021 to assess associations among BAT, melanoma progression, patient survival, and patient weight. We applied a three-stage universal BAT threshold definition using predetermined standardised uptake value thresholds of 0.8, 1.0, and 1.2 g/ml, given the retrospective nature of our study. Of the 135 patients (81 men and 54 women; median age 61 years, interquartile range 54-71), 40 (29.6%), 24 (17.8%), and 19 (14.1%) were BAT-positive at the 0.8, 1.0, and 1.2 g/ml thresholds, respectively. Results: = 0.030, respectively). Conclusions: No association between BAT positivity and relapse-free survival or overall survival was observed at any threshold. Although higher BAT volumes were observed in subgroups of patients who survived or did not relapse, these findings were not supported by survival analyses and should be considered exploratory.
No takes yet. Share an insight, caveat, or question.
Toivanen et al. (2026) conducted an observational in Cutaneous melanoma (n=135). Brown adipose tissue (BAT) activity vs. BAT negativity was evaluated on Relapse-free survival or overall survival. In patients with cutaneous melanoma, brown adipose tissue positivity was not associated with relapse-free survival or overall survival at any evaluated threshold.
Synapse has enriched 10 related papers. Consider them for comparative context: